STOCK TITAN

[144] CeriBell, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

CeriBell, Inc. (CBLL) submitted a Form 144 reporting a proposed sale of 866 common shares, with an aggregate market value of $10,142.93. The shares are part of a restricted stock vesting acquired on 08/20/2025 and paid as compensation. The sale is planned through Fidelity Brokerage Services LLC on 08/27/2025 and the securities trade on NASDAQ. The filer certifies no undisclosed material adverse information about the issuer. There were no sales by the filer in the prior three months reported.

CeriBell, Inc. (CBLL) ha presentato un modulo 144 per la vendita proposta di 866 azioni ordinarie, per un valore complessivo di mercato di $10.142,93. Le azioni fanno parte di un piano di restricted stock maturato e acquisito il 20/08/2025 e sono state corrisposte come compenso. La vendita è prevista tramite Fidelity Brokerage Services LLC il 27/08/2025 e i titoli sono quotati al NASDAQ. Il dichiarante certifica l'assenza di informazioni negative rilevanti non divulgate sull'emittente. Nei tre mesi precedenti non risulta alcuna vendita effettuata dal dichiarante.

CeriBell, Inc. (CBLL) presentó un Formulario 144 informando de la propuesta de venta de 866 acciones ordinarias, por un valor de mercado agregado de $10,142.93. Las acciones forman parte de acciones restringidas que vencieron y fueron adquiridas el 20/08/2025 y se pagaron como compensación. La venta está prevista a través de Fidelity Brokerage Services LLC el 27/08/2025 y los valores cotizan en el NASDAQ. El declarante certifica que no existen informaciones adversas materiales no divulgadas sobre el emisor. No se registraron ventas del declarante en los tres meses anteriores.

CeriBell, Inc. (CBLL)는 총액 $10,142.93에 해당하는 866 보통주 매도를 제안하는 Form 144를 제출했습니다. 해당 주식은 2025-08-20에 취득된 제한주(restricted stock) 베스팅분이며 보수로 지급된 것입니다. 매도는 2025-08-27Fidelity Brokerage Services LLC를 통해 이뤄질 예정이며, 증권은 NASDAQ에 상장되어 있습니다. 제출인은 발행인에 대한 미공개 중대한 불리한 정보가 없음을 확인합니다. 제출인은 지난 3개월 동안 매도를 보고하지 않았습니다.

CeriBell, Inc. (CBLL) a déposé un formulaire 144 signalant la vente projetée de 866 actions ordinaires, pour une valeur de marché totale de 10 142,93 $. Ces actions font partie d'actions restreintes acquises lors d'un vesting le 20/08/2025 et ont été versées en tant que rémunération. La vente est prévue par l'intermédiaire de Fidelity Brokerage Services LLC le 27/08/2025 et les titres sont cotés au NASDAQ. Le déclarant certifie qu'il n'existe aucune information défavorable matérielle non divulguée concernant l'émetteur. Aucune vente de la part du déclarant n'a été signalée au cours des trois mois précédents.

CeriBell, Inc. (CBLL) hat ein Formular 144 eingereicht und den geplanten Verkauf von 866 Stammaktien mit einem Gesamtmarktwert von $10.142,93 gemeldet. Die Aktien stammen aus einer restricted-stock-Zuteilung, die am 20.08.2025 erworben wurde und als Vergütung ausgezahlt wurde. Der Verkauf soll am 27.08.2025 über Fidelity Brokerage Services LLC erfolgen; die Papiere werden an der NASDAQ gehandelt. Der Einreichende bestätigt, dass keine nicht offengelegten wesentlichen nachteiligen Informationen über den Emittenten vorliegen. In den vorangegangenen drei Monaten wurden vom Einreichenden keine Verkäufe gemeldet.

Positive
  • Transparent disclosure of the proposed sale through Form 144 and identification of the broker and exchange
  • Securities originated from restricted stock vesting, indicating the sale is a routine conversion of compensation into liquid shares
  • No reported sales in prior three months, suggesting this is not part of a pattern of frequent insider dispositions
Negative
  • None.

Insights

TL;DR: Small insider sale of vested compensation shares; immaterial to capitalization but worth monitoring for insider behavior.

The filing shows a proposed sale of 866 shares valued at $10,142.93, representing a negligible portion of the company's outstanding common stock (36,663,968 shares). Since the shares were acquired via restricted stock vesting and paid as compensation, this is a routine liquidity event for an insider or employee rather than a market-driven divestiture. The transaction is unlikely to affect company valuation or market supply materially, but it does provide limited insight into insider selling behavior.

TL;DR: Routine compliance filing following vesting; demonstrates adherence to disclosure rules and Rule 144 requirements.

The Form 144 documents compliance with securities law for the proposed sale via an established broker and includes the required representations about material nonpublic information. The timing—acquisition on 08/20/2025 and planned sale on 08/27/2025—aligns with a typical post-vesting disposition. From a governance perspective, the filing is standard and reflects procedural transparency rather than a governance red flag.

CeriBell, Inc. (CBLL) ha presentato un modulo 144 per la vendita proposta di 866 azioni ordinarie, per un valore complessivo di mercato di $10.142,93. Le azioni fanno parte di un piano di restricted stock maturato e acquisito il 20/08/2025 e sono state corrisposte come compenso. La vendita è prevista tramite Fidelity Brokerage Services LLC il 27/08/2025 e i titoli sono quotati al NASDAQ. Il dichiarante certifica l'assenza di informazioni negative rilevanti non divulgate sull'emittente. Nei tre mesi precedenti non risulta alcuna vendita effettuata dal dichiarante.

CeriBell, Inc. (CBLL) presentó un Formulario 144 informando de la propuesta de venta de 866 acciones ordinarias, por un valor de mercado agregado de $10,142.93. Las acciones forman parte de acciones restringidas que vencieron y fueron adquiridas el 20/08/2025 y se pagaron como compensación. La venta está prevista a través de Fidelity Brokerage Services LLC el 27/08/2025 y los valores cotizan en el NASDAQ. El declarante certifica que no existen informaciones adversas materiales no divulgadas sobre el emisor. No se registraron ventas del declarante en los tres meses anteriores.

CeriBell, Inc. (CBLL)는 총액 $10,142.93에 해당하는 866 보통주 매도를 제안하는 Form 144를 제출했습니다. 해당 주식은 2025-08-20에 취득된 제한주(restricted stock) 베스팅분이며 보수로 지급된 것입니다. 매도는 2025-08-27Fidelity Brokerage Services LLC를 통해 이뤄질 예정이며, 증권은 NASDAQ에 상장되어 있습니다. 제출인은 발행인에 대한 미공개 중대한 불리한 정보가 없음을 확인합니다. 제출인은 지난 3개월 동안 매도를 보고하지 않았습니다.

CeriBell, Inc. (CBLL) a déposé un formulaire 144 signalant la vente projetée de 866 actions ordinaires, pour une valeur de marché totale de 10 142,93 $. Ces actions font partie d'actions restreintes acquises lors d'un vesting le 20/08/2025 et ont été versées en tant que rémunération. La vente est prévue par l'intermédiaire de Fidelity Brokerage Services LLC le 27/08/2025 et les titres sont cotés au NASDAQ. Le déclarant certifie qu'il n'existe aucune information défavorable matérielle non divulguée concernant l'émetteur. Aucune vente de la part du déclarant n'a été signalée au cours des trois mois précédents.

CeriBell, Inc. (CBLL) hat ein Formular 144 eingereicht und den geplanten Verkauf von 866 Stammaktien mit einem Gesamtmarktwert von $10.142,93 gemeldet. Die Aktien stammen aus einer restricted-stock-Zuteilung, die am 20.08.2025 erworben wurde und als Vergütung ausgezahlt wurde. Der Verkauf soll am 27.08.2025 über Fidelity Brokerage Services LLC erfolgen; die Papiere werden an der NASDAQ gehandelt. Der Einreichende bestätigt, dass keine nicht offengelegten wesentlichen nachteiligen Informationen über den Emittenten vorliegen. In den vorangegangenen drei Monaten wurden vom Einreichenden keine Verkäufe gemeldet.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does CeriBell's (CBLL) Form 144 report?

The filing reports a proposed sale of 866 common shares valued at $10,142.93, to be sold on 08/27/2025 via Fidelity Brokerage Services on NASDAQ.

How were the 866 shares acquired according to the filing?

The shares were acquired on 08/20/2025 through restricted stock vesting and the consideration is listed as compensation.

Does the filing indicate any undisclosed material information about CeriBell?

The signer represents that they do not know any material adverse information

Were there any securities sold by the filer in the prior three months?

The filing states Nothing to Report for securities sold during the past three months.

Who is the broker handling the proposed sale in the Form 144?

The broker listed is Fidelity Brokerage Services LLC located at the address provided in the filing.
CeriBell, Inc.

NASDAQ:CBLL

CBLL Rankings

CBLL Latest News

CBLL Latest SEC Filings

CBLL Stock Data

419.44M
28.88M
10.39%
84.32%
3.46%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
SUNNYVALE